Intentar ORO - Gratis
Sigachi isn't just a supplier; we are a strategic partner
Express Pharma
|December 2024
Amit Raj Sinha, MD and CEO, Sigachi explains that his company's strategic growth and diversification across excipients, APIs, food, nutrition, and personal care are driven by innovation, sustainability, and a customer-first approach. The company's focus on quality, regulatory compliance, and digital transformation positions it as a trusted global partner across industries
-
What differentiates Sigachi from competitors?
Sigachi stands as an industry leader with an unmatched production scale - 33000 MTPA for its excipients and nutritional premix range, allowing us to fulfill complex client demands with consistent quality and reliability. Our expertise spans multiple verticals, including APIs, excipients, food and nutritional ingredients, and personal care Ingredients, ensuring clients have access to an integrated, one-stop source for high-quality ingredients.
Our commitment to growth aligns with that of our customers growing needs and is reinforced by certain strategic projects, including the upcoming greenfield facility in Dahej SEZ. The state-of-the-art facility will expand our production capacity, support innovation, and set new standards for operational excellence within the industry.
Sigachi's customer-centric approach, combined with a strong emphasis on sustainable operations - from eco-friendly sourcing to waste reduction positions us as a responsible and sustainable, trusted partner. Additionally, our dedication to innovation is supported by continuous R&D investment, poised to grow from a lower single-digit to a mid-single-digit percentage of revenue. Our R&D facility, recognised and approved by Department of Scientific and Industrial Research, Government of India, leads advancements in excipient development and multifunctional ingredient solutions, providing clients with cutting-edge, high-quality products.
Sigachi isn't just a supplier; we are a strategic partner, dedicated to delivering excellence, fostering sustainable growth, and supporting clients across diverse sectors with reliability and agility.
Sigachi has expanded significantly from MCC excipients to APIs, food, nutrition, and personal care. What prompted this diversification, and how do you ensure cohesive growth across such varied sectors?
Esta historia es de la edición December 2024 de Express Pharma.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Listen
Translate
Change font size
